Comparing Interfractional Stability of Heart Dose Among Three Breath-Hold Radiotherapy Techniques in Breast Cancer.

IF 3.2 3区 医学 Q2 ONCOLOGY
A W Chan, A Hoang, H Chen, M McGuffin, A Sheikh, D Vesprini, L Zhang, M Wronski, I Karam
{"title":"Comparing Interfractional Stability of Heart Dose Among Three Breath-Hold Radiotherapy Techniques in Breast Cancer.","authors":"A W Chan, A Hoang, H Chen, M McGuffin, A Sheikh, D Vesprini, L Zhang, M Wronski, I Karam","doi":"10.1016/j.clon.2024.103699","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Breath holding can reduce the cardiac dose in radiotherapy for left-sided breast cancer. We evaluated whether any of the existing commonly used breath-hold techniques was superior in maintaining a more reproducible mean heart dose (MHD) during treatment.</p><p><strong>Materials and methods: </strong>This was a single-institution, interventional, nonrandomised, three-armed prospective trial, comparing the reproducibility of MHD in breath-hold radiotherapy using voluntary deep inspiration breath hold (vDIBH), active breathing control (ABC), and surface-guided radiotherapy (SGRT). The MHDs were determined based on the anatomy in planning computed tomography (CT) and each weekly cone beam computed tomography (CBCT) during radiotherapy. The reproducibility of MHD was measured by calculating the interfractional variation of MHD (represented by the standard deviation) across the CBCT and the difference between the cumulative MHD at CBCT and at planning CT. These two measures of reproducibility were then compared among vDIBH, ABC, and SGRT.</p><p><strong>Results: </strong>Of the 55 patients recruited, 19 had ABC, 20 had SGRT, and 16 had vDIBH. SGRT was associated with a slightly greater interfractional variation of the MHD than vDIBH (least squares mean (LSM): 28.8 cGy (SGRT) vs 10.5 cGy (vDIBH), P = 0.0052) and ABC (LSM: 28.8 cGy (SGRT) vs 15.1 cGy (ABC), P = 0.026). In the SGRT group, the cumulative MHD at CBCT was lower than that at planning CT (mean difference: -22.1 cGy, P = 0.013). No such difference existed in vDIBH and ABC. In terms of the reproducibility of cumulative MHD at CBCT as compared to that in planning CT, there was no significant difference between vDIBH (mean: -12.1 cGy), ABC (mean: -4.8 cGy), and SGRT (mean: -22.1 cGy) (P value for pairwise comparison: all >0.1).</p><p><strong>Conclusions: </strong>SGRT was associated with a slightly greater interfractional variation of MHD than vDIBH and ABC, but the difference may not be clinically significant. All three breath-hold techniques were broadly comparable in their reproducibility of MHD at CBCT relative to the planning CT.</p>","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"38 ","pages":"103699"},"PeriodicalIF":3.2000,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.clon.2024.103699","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: Breath holding can reduce the cardiac dose in radiotherapy for left-sided breast cancer. We evaluated whether any of the existing commonly used breath-hold techniques was superior in maintaining a more reproducible mean heart dose (MHD) during treatment.

Materials and methods: This was a single-institution, interventional, nonrandomised, three-armed prospective trial, comparing the reproducibility of MHD in breath-hold radiotherapy using voluntary deep inspiration breath hold (vDIBH), active breathing control (ABC), and surface-guided radiotherapy (SGRT). The MHDs were determined based on the anatomy in planning computed tomography (CT) and each weekly cone beam computed tomography (CBCT) during radiotherapy. The reproducibility of MHD was measured by calculating the interfractional variation of MHD (represented by the standard deviation) across the CBCT and the difference between the cumulative MHD at CBCT and at planning CT. These two measures of reproducibility were then compared among vDIBH, ABC, and SGRT.

Results: Of the 55 patients recruited, 19 had ABC, 20 had SGRT, and 16 had vDIBH. SGRT was associated with a slightly greater interfractional variation of the MHD than vDIBH (least squares mean (LSM): 28.8 cGy (SGRT) vs 10.5 cGy (vDIBH), P = 0.0052) and ABC (LSM: 28.8 cGy (SGRT) vs 15.1 cGy (ABC), P = 0.026). In the SGRT group, the cumulative MHD at CBCT was lower than that at planning CT (mean difference: -22.1 cGy, P = 0.013). No such difference existed in vDIBH and ABC. In terms of the reproducibility of cumulative MHD at CBCT as compared to that in planning CT, there was no significant difference between vDIBH (mean: -12.1 cGy), ABC (mean: -4.8 cGy), and SGRT (mean: -22.1 cGy) (P value for pairwise comparison: all >0.1).

Conclusions: SGRT was associated with a slightly greater interfractional variation of MHD than vDIBH and ABC, but the difference may not be clinically significant. All three breath-hold techniques were broadly comparable in their reproducibility of MHD at CBCT relative to the planning CT.

三种屏气放疗治疗乳腺癌患者心脏剂量的分次稳定性比较。
目的:在左侧乳腺癌放疗中,屏气可降低心脏剂量。我们评估了在治疗期间是否有任何现有常用的屏气技术在维持更可重复的平均心脏剂量(MHD)方面具有优势。材料和方法:这是一项单机构、干预性、非随机、三臂前瞻性试验,比较MHD在采用自主深吸气屏气(vDIBH)、主动呼吸控制(ABC)和表面引导放疗(SGRT)的屏气放疗中的可重复性。在放射治疗期间,通过计划计算机断层扫描(CT)和每周锥形束计算机断层扫描(CBCT)确定MHDs。通过计算整个CBCT中MHD的分数间变化(以标准差表示)以及CBCT和计划CT累积MHD之间的差异来测量MHD的可重复性。然后在vDIBH、ABC和SGRT之间比较这两个可重复性指标。结果:在招募的55例患者中,19例有ABC, 20例有SGRT, 16例有vDIBH。SGRT与MHD分数间变化的相关性略高于vDIBH(最小二乘平均值(LSM): 28.8 cGy (SGRT) vs 10.5 cGy (vDIBH), P = 0.0052)和ABC (LSM: 28.8 cGy (SGRT) vs 15.1 cGy (ABC), P = 0.026)。SGRT组CBCT累积MHD低于计划CT(平均差值:-22.1 cGy, P = 0.013)。在vDIBH和ABC中不存在这种差异。与计划CT相比,CBCT累积MHD的再现性方面,vDIBH(平均值:-12.1 cGy)、ABC(平均值:-4.8 cGy)和SGRT(平均值:-22.1 cGy)之间无显著差异(两两比较的P值:均为0.1)。结论:SGRT与MHD分数间变化的相关性略高于vDIBH和ABC,但差异可能没有临床意义。与计划CT相比,这三种屏气技术在CBCT上的MHD再现性大致相当。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical oncology
Clinical oncology 医学-肿瘤学
CiteScore
5.20
自引率
8.80%
发文量
332
审稿时长
40 days
期刊介绍: Clinical Oncology is an International cancer journal covering all aspects of the clinical management of cancer patients, reflecting a multidisciplinary approach to therapy. Papers, editorials and reviews are published on all types of malignant disease embracing, pathology, diagnosis and treatment, including radiotherapy, chemotherapy, surgery, combined modality treatment and palliative care. Research and review papers covering epidemiology, radiobiology, radiation physics, tumour biology, and immunology are also published, together with letters to the editor, case reports and book reviews.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信